Marie Roskrow
Voorzitter bij LYTIX BIOPHARMA
Vermogen: - $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Marie Roskrow
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 14 | |
| Public Company | Pharmaceuticals: Major | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Marie Roskrow via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| University of Oslo | College/University | Undergraduate Degree Graduate Degree Doctorate Degree | |
| University of Tromso | College/University | Corporate Officer/Principal Doctorate Degree | |
| PHOTOCURE ASA | Medical Specialties | Chief Executive Officer Chief Operating Officer | |
| University of Uppsala | College/University | Doctorate Degree Corporate Officer/Principal | |
| BI Norwegian Business School | College/University | Masters Business Admin Graduate Degree | |
GE Healthcare AS
 GE Healthcare AS Medical SpecialtiesHealth Technology GE Healthcare AS markets contrast agent for x-ray, ultrasound, Magnetic Resonance Imaging, and radiopharmaceuticals for clinicians to predict, diagnose, inform, and treat diseases. The company was founded on September 07, 1981 and it is headquartered in Oslo, Norway. | Medical Specialties | Chief Executive Officer Corporate Officer/Principal | |
| PRECIGEN, INC. | Biotechnology | Corporate Officer/Principal Private Equity Investor | |
| AVID BIOSERVICES, INC. | Biotechnology | Corporate Officer/Principal | |
| Rollins College (Florida) | College/University | Undergraduate Degree | |
| University of Virginia Darden School of Business | College/University | Masters Business Admin | |
| University of Virginia | College/University | Doctorate Degree | |
PBM Capital Group LLC
 PBM Capital Group LLC Investment ManagersFinance PBM Capital Group LLC (PBM Capital Group) is a private equity and venture capital firm founded in 2010 by Paul B. Manning. The firm is headquartered in Charlottesville, Virginia. | Investment Managers | Private Equity Investor | |
| VERRICA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Operating Officer | |
Xalud Therapeutics, Inc.
 Xalud Therapeutics, Inc. BiotechnologyHealth Technology Xalud Therapeutics, Inc. develops novel therapies with several promising therapeutic programs for inflammatory. The firm offers XT-101, a single dosage injection that stops disease progression, eliminates neuropathic pain, and reverses paralysis. It also researches on the applicability of XT-101 for multiple sclerosis and amyotrophic lateral sclerosis. The company was founded by John Forsayeth and Linda Watkins and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
ZP Opco, Inc.
 ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology ZP Opco, Inc. operates as a biopharmaceutical company that develops transdermal delivery technology for therapeutic indications. The company was founded by Peter E. Daddona and Frank D. Stonebanks in 2006 and is headquartered in Fremont, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Idia AS
 Idia AS Food: Major DiversifiedConsumer Non-Durables Idia AS provides nutritional ingredient. It offers ingredient to the food and beverage industries. The company was founded by Ole Peter Nordby and is headquartered in Oslo, Norway. | Food: Major Diversified | Founder | |
| OHM Technologies | Corporate Officer/Principal | ||
Pre Diagnostics AS
 Pre Diagnostics AS Medical/Nursing ServicesHealth Services Pre Diagnostics AS develops in-vitro diagnostic (IVD) products for early detection of diseases. It focuses on the development of IVD biomarker products that use well-established technologies and procedures. The company was founded by Ole Peter Nordby, Hakon Saeteroy, and Erik Christensen on October 25, 2013 and is headquartered in Oslo, Norway. | Medical/Nursing Services | Founder | |
Centrose LLC
 Centrose LLC Pharmaceuticals: MajorHealth Technology Centrose LLC discovers and develops therapeutics. It focuses on the chemistry and biology unique to the creation of EDC technology. The company was founded by James R. Prudent in 2007 and is headquartered in Middleton, WI. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Prophylix AS
 Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Pharmaceuticals: Major | Director/Board Member | |
| SERODUS ASA | Biotechnology | Director/Board Member | |
Svenska Handelsbanken AB (Broker)
 Svenska Handelsbanken AB (Broker) Investment Banks/BrokersFinance Svenska Handelsbanken AB (Broker) (Handelsbanken-Broker) is the broker/dealer division of Svenska Handelsbanken AB (STO: SHB-A; OTCMKTS: SVNLY) in Sweden. Headquartered in Stockholm, Handelsbanken-Broker was founded in 1871 and provides trading services to large corporates. The firm trades in equities, money market instruments, currencies, commodities and derivatives. | Investment Banks/Brokers | Analyst-Equity | |
Storm Capital Management AS
 Storm Capital Management AS Investment ManagersFinance Storm Capital Management AS (SCM) is an asset management firm headquartered in Oslo, Norway. The firm was founded in 2006 by Morten Astrup. SCM focuses exclusively on the management of Storm Bond Fund, a Nordic Corporate Bond Fund (UCITS). | Investment Managers | Portfolio Manager-Equities | |
Redwood Bioscience, Inc.
 Redwood Bioscience, Inc. BiotechnologyHealth Technology Redwood Bioscience Inc. develops precision protein-chemical engineering technology to produce the next-generation of antibody-drug conjugates and other semi-synthetic biotherapeutics. It employs natural post translational modifications found in human cells to site specifically create one or more aldehyde tags on protein molecules, including monoclonal antibodies. The firm's platform is enabled with precision chemistries, payload positioning and defined stoichiometry of payload protein ratios. The company was founded by Carolyn R. Bertozzi, Mike Blank and David Rabuka in 2008 and is headquartered in Emeryville, CA. | Biotechnology | Corporate Officer/Principal | |
Indi Molecular, Inc.
 Indi Molecular, Inc. BiotechnologyHealth Technology Indi Molecular, Inc. is a life sciences company that develops a synthetic class of diagnostic and therapeutic agents with antibody-like properties: protein-catalyzed capture agents. It offers products used by physicians and patients to manage complex and serious diseases like cancer, diabetes, and Alzheimer's. The company was founded by Michael Phelps, Albert A. Luderer, Leroy E. Hood, and Jim Heath in 2013 and is headquartered in Culver City, CA. | Biotechnology | Corporate Officer/Principal | |
| SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Awilhelmsen Management AS
 Awilhelmsen Management AS Marine ShippingTransportation Awilhelmsen Management AS engages in shipping, offshore, real estate, cruise, and financial holding services. The company was founded in 1990 and is headquartered in Oslo, Norway. | Marine Shipping | Director/Board Member | |
| IMMUNE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Telstra Corp. Ltd.
 Telstra Corp. Ltd. Specialty TelecommunicationsCommunications Telstra Corp. Ltd. engages in the provision of telecommunications and information services for domestic and international customers. It operates through the following segments: Telstra Consumer and Small Business, Telstra Enterprise, Networks and IT, Telstra InfraCo, and All Others. The Telstra Consumer and Small Business segment comprises of telecommunication products, services, and solutions across mobiles, fixed and mobile broadband, telephony and play TV/IPTV, and digital content to consumer and small business customers in Australia. The Telstra Enterprise segment sells and contracts management for medium to large businesses, and government customers globally. The Networks and IT segment is responsible for the overall planning, design, engineering architecture, and construction of Telstra networks, technology, and information technology solutions. The Telstra InfraCo segment provides a range of telecommunication products and services delivered over Telstra networks and associated support systems to other carriers, carriage service providers, and internet service providers. The All Other segments include certain items of income and expense relating to multiple reportable segments that are recorded by its corporate areas. The company was founded in 1901 and is headquartered in Melbourne, Australia. | Specialty Telecommunications | General Counsel | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| PASITHEA THERAPEUTICS CORP. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Tolerion, Inc.
 Tolerion, Inc. Pharmaceuticals: MajorHealth Technology Tolerion, Inc. operates as a clinical-stage biopharmaceutical firm. It develops and commercializes therapeutics. The firm provides TOL-3034 and TOL-3052 to treat myasthenia gravis and neuromyelitis optica. The company was founded by Lawrence J. Steinman and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Biotechnology | Chief Operating Officer | |
| University of Aston | College/University | Doctorate Degree | |
| PDL BIOPHARMA, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| GILEAD SCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Copenhagen Business School | College/University | Graduate Degree | |
| EXSCIENTIA PLC | Biotechnology | Chief Tech/Sci/R&D Officer | |
| BIOVICA INTERNATIONAL AB | Biotechnology | Director/Board Member | |
| FARON PHARMACEUTICALS OY | Pharmaceuticals: Major | Director/Board Member | |
| MERUS N.V. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| DNA Ink LLC | Founder | ||
| SENSEI BIOTHERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Heriot-Watt University | College/University | Masters Business Admin | |
Ilya Pharma AB
 Ilya Pharma AB BiotechnologyHealth Technology Ilya Pharma AB develops biological drugs for treating wounds in skin and mucosa. The company was incorporated in May 13, 2016 by Mia Johanna Phillipson, Stefan Roos and Evelina Wanda Matilda Vågesjö and is headquartered in Uppsala, Sweden. | Biotechnology | Chief Executive Officer | |
| RMIT University | College/University | Graduate Degree | |
| Griffith University | College/University | Undergraduate Degree | |
Red Bay Coffee Co., Inc.
 Red Bay Coffee Co., Inc. Food RetailRetail Trade Red Bay Coffee Co., Inc. operates as wholesale specialty coffee roasting company. Its specializes in specialty coffee, coffee roasting, manufacturing, coffee education, and coffee programs. The company was founded by Keba Konte and Kori Saika Chen in 2014 and is headquartered in Oakland, CA. | Food Retail | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 26 |
| Noorwegen | 12 |
| Zweden | 5 |
| Australië | 4 |
| Verenigd Koninkrijk | 4 |
Sectoraal
| Health Technology | 29 |
| Consumer Services | 13 |
| Finance | 4 |
| Consumer Non-Durables | 2 |
| Health Services | 2 |
Operationeel
| Director/Board Member | 41 |
| Corporate Officer/Principal | 27 |
| Chairman | 20 |
| Chief Executive Officer | 16 |
| Chief Tech/Sci/R&D Officer | 13 |
Sterkste connecties
- Beurs
- Insiders
- Marie Roskrow
- Bedrijfsconnecties
